Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
71 people
NVIDIA
Santa ClaraPre-Seed–Growth
17 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
58 people
IMM Investment Japan
TokyoSeed–Growth
21 people
SBI Investment Korea Co. Ltd.
SeoulSeries A–Series C$200K – $10M
33 people
Dementia Discovery Fund
LondonSeed–Late Stage
81 people
Elaia
ParisSeed–Series C$108K – $1.6M
45 people
Novo Holdings
HellerupSeed–Late Stage$1.1M – $54M
48 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
40 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
82 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
55 people
Polaris Partners
BostonSeed–Growth$500K – $5M
45 people
Radical Ventures
TorontoSeed–Series C$1M – $25M
46 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Stifel Venture Banking
San FranciscoSeed–Late Stage
75 people
HLM Investment Partners
WalthamSeries A–Growth$3M – $5M
35 people
SMBC Venture Capital
TokyoPre-Seed–Late Stage
27 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiSeed–Late Stage$5.4M – $16.2M
24 people
Cambridge Innovation Capital
CambridgeSeed–Growth$127K – $12.7M
57 people
Pitango
Tel AvivSeed–Growth$2M – $40M
39 people
Eight Roads Ventures
MumbaiSeed–Growth$5M – $30M
33 people
Hummingbird Ventures
BrusselsPre-Seed–Growth$500K – $10M
40 people
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
51 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.








































































































